Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;6(10):1076-1084.
doi: 10.1016/j.eng.2020.10.003. Epub 2020 Oct 15.

Strategies and Advances in Combating COVID-19 in China

Wei Liu  1 , Wei-Jie Guan  1 , Nan-Shan Zhong  1
Affiliations
Review

Strategies and Advances in Combating COVID-19 in China

Wei Liu et al. Engineering (Beijing). 2020 Oct.

Abstract

Coronavirus disease 2019 (COVID-19)-the third in a series of coronavirus infections-has caused a global public health event in the 21st century, resulting in substantial global morbidity and mortality. Building on its legacy of managing severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), China has played a key role in the scientific community by revealing the viral transmission routes and clinical characteristics of COVID-19 and developing novel therapeutic interventions and vaccines. Despite these rapid scientific and technological advances, uncertainties remain in tracing the original sources of infection, determining the routes of transmission and pathogenesis, and addressing the lack of targeted clinical management of COVID-19. Here, we summarize the major COVID-19 research advances in China in order to provide useful information for global pandemic control.

Keywords: Angiotensin-converting enzyme; Clinical characteristics; Coronavirus disease 2019; Immune response; Inflammation; Treatment; Vaccine.

PubMed Disclaimer

References

    1. Lu R., Zhao X., Li J., Niu P., Yang B., Wu H. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574. - PMC - PubMed
    1. Brielle E.S., Schneidman-Duhovny D., Linial M. The SARS-CoV-2 exerts a distinctive strategy for interacting with the ACE2 human receptor. Viruses. 2020;12(5):497. - PMC - PubMed
    1. Hu T., Liu Y., Zhao M., Zhuang Q., Xu L., He Q. A comparison of COVID-19, SARS and MERS. Peer J. 2020;8 - PMC - PubMed
    1. Su S., Wong G., Shi W., Liu J., Lai A.C.K., Zhou J. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016;24(6):490–502. - PMC - PubMed
    1. Naqvi A.A.T., Fatima K., Mohammad T., Fatima U., Singh I.K., Singh A. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach. Biochim Biophys Acta Mol Basis Dis. 2020;1866(10) - PMC - PubMed

LinkOut - more resources